Fletcher Horace, Wharfe Gilian, Williams Elaine, Hanchard Barrie, Mitchell Derek
Department of Obstetrics and Gynaecology, University of the West Indies, Mona, Kingston, Jamaica.
J Med Case Rep. 2007 May 2;1:15. doi: 10.1186/1752-1947-1-15.
We present a 61 year old Para 4 woman who presented with stage II Infiltrating lobular carcinoma of the breast after modified radical mastectomy. She was treated with Tamoxifen for seven years. She was diagnosed with multiple myeloma during year seven post mastectomy because of wrist pain. She was treated with melphalan, prednisone and allopurinol which she tolerated well and the pain in the wrist improved. Tamoxifen was also stopped. Ten months later she presented with vaginal bleeding and was diagnosed with a poorly differentiated endometrial adenocarcinoma at hysteroscopic suction curettage and had an abdominal hysterectomy. Two years later the patient succumbed to metastatic endometrial cancer.
我们报告一位61岁、孕4产4的女性,她在改良根治性乳房切除术后被诊断为II期浸润性小叶乳腺癌。她接受了7年的他莫昔芬治疗。乳房切除术后第7年,她因手腕疼痛被诊断为多发性骨髓瘤。她接受了美法仑、泼尼松和别嘌醇治疗,耐受性良好,手腕疼痛有所改善。他莫昔芬也停用了。10个月后,她出现阴道出血,在宫腔镜吸刮术中被诊断为低分化子宫内膜腺癌,并接受了腹式子宫切除术。两年后,患者死于转移性子宫内膜癌。